Valuation : Beta Bionics, Inc.

Market Cap 75Cr 64Cr 61Cr 55Cr 103.42Cr 7.12TCr 103.94Cr 722.32Cr 277.77Cr 3.62TCr 279.97Cr 273.83Cr 11TCr P/E 2026 *
-7.76x
P/E 2027 * -7.71x
Enterprise Value 61Cr 53Cr 50Cr 45Cr 85Cr 5.84TCr 85Cr 592.77Cr 227.95Cr 2.97TCr 229.76Cr 224.72Cr 9.4TCr EV / Sales 2026 *
4.57x
EV / Sales 2027 * 3.74x
Free-Float
98.89%
Yield 2026 *
-
Yield 2027 * -
1 day-0.12%
1 week-14.68%
Current month-16.94%
1 month-5.96%
3 months+12.80%
6 months+52.44%
Current year-45.62%
1 week 15.84
Extreme 15.845
19.54
1 month 15.84
Extreme 15.845
20.74
Current year 8.8
Extreme 8.8
32.58
1 year 8.8
Extreme 8.8
32.71
3 years 8.8
Extreme 8.8
32.71
5 years 8.8
Extreme 8.8
32.71
10 years 8.8
Extreme 8.8
32.71
Manager TitleAgeSince
Chief Executive Officer 50 15/08/2022
Director of Finance/CFO 37 01/08/2022
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Director/Board Member 57 01/02/2020
Director/Board Member 50 15/08/2022
Director/Board Member 63 01/10/2024
Date Insider Type Main position Quantity % Market Cap. Importance
03/09/26 Sell

Chief Executive Officer

-5,641 0.0125%
02/09/26 Sell

Executive/Senior Manager

-4,375 0.0097%
02/09/26 Sell

Executive/Senior Manager

-5,327 0.0118%
Change 5-day change 1-year change 3-year change Capi.($)
-0.12%-14.68%-34.61% - 75Cr
+1.10%-0.65%+24.10%+18.43% 22TCr
-0.19%-3.62%+2.55%-20.00% 14TCr
+2.41%+0.67%-19.02%+22.09% 13TCr
-0.28%-10.08%-58.81%-21.22% 6.25TCr
-0.49%-1.97%-20.35%-15.53% 4.97TCr
-2.77%-6.15%+8.15%+12.69% 5TCr
+2.66%-2.61%+15.94%+29.91% 4.03TCr
+1.67%-0.25%+35.01%+55.09% 3.95TCr
-0.60%-4.41%-20.52%+44.06% 3.14TCr
Average +0.34%-4.87%-6.76%+13.95% 7.66TCr
Weighted average by Cap. +0.51%-3.07%+0.51%+9.68%

Financials

2026 *2027 *
Net sales 13Cr 12Cr 11Cr 9.9Cr 19Cr 1.28TCr 19Cr 129.73Cr 50Cr 650.73Cr 50Cr 49Cr 2.06TCr 18Cr 15Cr 15Cr 13Cr 25Cr 1.72TCr 25Cr 174.07Cr 67Cr 873.19Cr 67Cr 66Cr 2.76TCr
Net income -9.49Cr -8.18Cr -7.74Cr -7.02Cr -13Cr -906.68Cr -13Cr -92Cr -35Cr -461.28Cr -36Cr -35Cr -1.46TCr -9.64Cr -8.31Cr -7.87Cr -7.13Cr -13Cr -921.31Cr -13Cr -93Cr -36Cr -468.72Cr -36Cr -35Cr -1.48TCr
Net Debt -13Cr -12Cr -11Cr -9.89Cr -19Cr -1.28TCr -19Cr -129.55Cr -50Cr -649.87Cr -50Cr -49Cr -2.05TCr -7.33Cr -6.32Cr -5.98Cr -5.42Cr -10Cr -700.47Cr -10Cr -71Cr -27Cr -356.37Cr -28Cr -27Cr -1.13TCr
Logo Beta Bionics, Inc.
Beta Bionics, Inc. is a commercial-stage medical device company engaged in the design, development and commercialization of various solutions to improve the health of insulin-requiring people with diabetes (PWD). The Company's product, the iLet Bionic Pancreas (iLet), is an insulin delivery device cleared by the United States Food and Drug Administration (FDA) to utilize adaptive closed-loop algorithms to autonomously determine every insulin dose without requiring a user to count carbohydrate intake. iLet is used for the treatment of Type 1 diabetes (T1D). The Company's solutions include iLet for Adults, iLet for Children, Bionic Circle App and iLet Simulator. The Company is in the early stages of developing an insulin pump that is designed to adhere directly to the skin and administer insulin without the need for tubing, commonly known in the diabetes industry as a patch pump. It is also in the early stages of developing a bihormonal configuration of the iLet.
Employees
422
Date Price Change Volume
11/26/11 $16.57 -0.12% 7,26,142
10/26/10 $16.59 -4.76% 9,57,711
09/26/09 $17.42 -9.88% 8,48,749
08/26/08 $19.33 -0.46% 9,00,833
04/26/04 $19.42 -2.51% 14,07,468
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
12
Last Close Price
16.57USD
Average target price
20.31USD
Spread / Average Target
+22.57%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. BBNX Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!